Sfoglia per AUTORE
FABBROCINI G
Collezione AOU Novara

  

Items : 10

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1:7-14. doi: 10.1111/jdv.20187. Epub 2024 Jun 26.
2025
AOU Novara

Bonifati C; Lembo S; Richetta AG; Romanelli M; Satolli F; Corazza M; Atzori L; Lasagni C; Potenza C; Savoia P; Bardazzi F; Di Lernia VG; Bianchi L; Fabbrocini G; Giofrè C; Zichichi L; Guarneri C; Pallotta S; Fargnoli MC; Loconsole F; Offidani A; Burlando M; Piaserico S; Peris K; Papini M; Carrera CG; Costanzo A; Prignano F; Bongiorno MR; et alii...

A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18.
2023
AOU Novara

Stingeni L; Bianchi L; Antonelli E; Caroppo ES; Ferrucci SM; Gurioli C; Ortoncelli M; Fabbrocini G; Nettis E; Schena D; Napolitano M; Gola M; Bonzano L; Rossi M; Belloni Fortina A; Balato A; Peris K; Foti C; Guarneri F; Romanelli M; Patruno C; Savoia P; Esposito M; Russo F; Errichetti E; Bianchelli T; Bianchi L; Pellacani G; Feliciani C; et alii...

Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study. in Advances in therapy / Adv Ther. 2023 Jul;40(7):3021-3037. doi: 10.1007/s12325-023-02516-y. Epub 2023 May 12.
2023
AOU Novara

Giofrè C; Fabbrocini G; Potenza C; Tiberio R; Gisondi P; Marasca C; Nuzzo CMA; Benincasa E; Bianchi L;

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years. in The Journal of dermatological treatment / J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602.
2023
AOU Città della Salute di Torino
AOU Novara

Picone V; di Vico F; Chiodini P; Vallone Y; Fargnoli MC; Esposito M; Satta R; Dragoni F; Termine S; Pezzolo E; Gruber M; Berti SF; Veronese F; Zangari P; Ferreli C; Patella V; Peduto T; Moschese V; Russo D; Di Pillo S; Palermo A; Marseglia GL; Leonardi S; Licari A; Provenzano E; Amoruso FG; Guerriero C; De Simone C; Chiricozzi A; et alii...

National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis. in Journal of clinical medicine / J Clin Med. 2022 Sep 2;11(17):5204. doi: 10.3390/jcm11175204.
2022
AOU Novara

Gori N; Chiricozzi A; Marsili F; Ferrucci SM; Amerio P; Battarra V; Campitiello S; Castelli A; Congedo M; Corazza M; Cristaudo A; Fabbrocini G; Girolomoni G; Malara G; Micali G; Palazzo G; Parodi A; Patrizi A; Pellacani G; Pigatto P; Provenzano E; Quaglino P; Romanelli M; Rossi M; Savoia P; Peris K;

Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2022 Mar;22(3):367-376. doi: 10.1080/14712598.2022.1988566. Epub 2021 Oct 12.
2022
AOU Novara

Galluzzo M; Chiricozzi A; Cinotti E; Brunasso G; Congedo M; Esposito M; Franchi C; Malara G; Narcisi A; Piaserico S; Tiberio R; Argenziano G; Fabbrocini G; Parodi A;

Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1292-1299. doi: 10.1111/jdv.18141. Epub 2022 Apr 22.
2022
AOU Novara

Stingeni L; Bianchi L; Antonelli E; Caroppo ES; Ferrucci SM; Ortoncelli M; Fabbrocini G; Nettis E; Schena D; Napolitano M; Gola M; Bonzano L; Rossi M; Belloni Fortina A; Balato A; Peris K; Foti C; Guarneri F; Romanelli M; Patruno C; Savoia P; Fargnoli MC; Russo F; Errichetti E; Bianchelli T; Bianchi L; Pellacani G; Feliciani C; Offidani A; et alii...

2021
AOU Novara

Chiricozzi A; Talamonti M; De Simone C; Galluzzo M; Gori N; Fabbrocini G; Marzano AV; Girolomoni G; Offidani A; Rossi MT; Bianchi L; Cristaudo A; Fierro MT; Stingeni L; Pellacani G; Argenziano G; Patrizi A; Pigatto P; Romanelli M; Savoia P; Rubegni P; Foti C; Milanesi N; Belloni Fortina A; Bongiorno MR; Grieco T; Di Nuzzo S; Fargnoli MC; Carugno A; et alii...

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13.
2021
AOU Novara

Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; et alii...

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e770-e772. doi: 10.1111/jdv.16841. Epub 2020 Aug 10.
2020
AOU Novara

Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Belloni Fortina A; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Venturini M; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavò SP; et alii...

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte